FDA Invites Manufacturers, Ad Agencies To Discuss DTC Ad Designs
Executive Summary
FDA would like to consult with pharmaceutical companies and their advertising agencies early on in the development of direct-to-consumer advertising campaigns
You may also be interested in...
Ads For New Drugs Would Require FDA Preclearance Under Rx Safety Bill
Promotional materials for recently-approved drugs would receive special scrutiny by the Center for Postmarket Drug Evaluation & Research proposed in Senate legislation
Ads For New Drugs Would Require FDA Preclearance Under Rx Safety Bill
Promotional materials for recently-approved drugs would receive special scrutiny by the Center for Postmarket Drug Evaluation & Research proposed in Senate legislation
Celebrex, Bextra Ads Draw Fire From FDA; Reminder Of “Reminder” Ad Rules
An FDA "untitled" letter to Pfizer on Celebrex and Bextra is the agency's second recent objection to the company's interpretation of the boundaries of "reminder" ads